tiprankstipranks
Trending News
More News >
Arterra Bioscience SpA (IT:ARBS)
:ARBS
Italy Market

Arterra Bioscience SpA (ARBS) Ratios

Compare
0 Followers

Arterra Bioscience SpA Ratios

IT:ARBS's free cash flow for Q2 2025 was €0.19. For the 2025 fiscal year, IT:ARBS's free cash flow was decreased by € and operating cash flow was €0.42. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.64 9.99 9.35 11.18 12.08
Quick Ratio
7.34 8.37 7.74 9.86 11.39
Cash Ratio
3.47 4.06 4.37 5.01 6.85
Solvency Ratio
0.95 0.85 0.89 0.93 0.76
Operating Cash Flow Ratio
1.92 1.29 1.22 1.59 1.99
Short-Term Operating Cash Flow Coverage
39.54 11.04 11.88 8.01 6.26
Net Current Asset Value
€ 6.22M€ 6.25M€ 6.08M€ 7.70M€ 6.38M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.03 0.03 0.04 0.05
Debt-to-Equity Ratio
0.03 0.03 0.04 0.05 0.06
Debt-to-Capital Ratio
0.03 0.03 0.03 0.04 0.06
Long-Term Debt-to-Capital Ratio
0.02 0.02 0.03 0.03 0.04
Financial Leverage Ratio
1.20 1.17 1.17 1.20 1.22
Debt Service Coverage Ratio
45.68 17.17 16.80 9.62 6.93
Interest Coverage Ratio
1.08K 1.08K -152.98 48.60 59.26
Debt to Market Cap
0.01 0.03 0.03 0.03 0.03
Interest Debt Per Share
0.05 0.05 0.06 0.07 0.09
Net Debt to EBITDA
-1.27 -1.46 -1.79 -1.83 -2.38
Profitability Margins
Gross Profit Margin
19.30%87.46%55.46%13.83%17.60%
EBIT Margin
47.95%40.81%39.33%50.65%33.45%
EBITDA Margin
55.08%48.94%55.29%59.84%46.18%
Operating Profit Margin
15.66%35.19%-45.97%10.24%12.64%
Pretax Profit Margin
47.94%40.77%39.03%50.44%33.23%
Net Profit Margin
42.38%32.03%32.26%39.68%29.03%
Continuous Operations Profit Margin
42.38%32.03%32.26%39.68%29.03%
Net Income Per EBT
88.41%78.56%82.64%78.67%87.36%
EBT Per EBIT
306.10%115.85%-84.90%492.41%262.98%
Return on Assets (ROA)
13.59%9.97%8.57%11.25%9.59%
Return on Equity (ROE)
16.50%11.70%10.01%13.51%11.72%
Return on Capital Employed (ROCE)
5.41%11.68%-13.10%3.12%4.44%
Return on Invested Capital (ROIC)
4.76%9.10%-10.74%2.45%3.79%
Return on Tangible Assets
13.62%10.00%8.60%11.29%9.70%
Earnings Yield
8.46%10.24%9.74%9.83%5.75%
Efficiency Ratios
Receivables Turnover
1.17 1.29 1.66 1.34 1.20
Payables Turnover
7.57 1.90 5.95 16.35 12.60
Inventory Turnover
2.81 0.39 1.10 2.65 6.46
Fixed Asset Turnover
2.56 2.77 2.71 2.32 2.30
Asset Turnover
0.32 0.31 0.27 0.28 0.33
Working Capital Turnover Ratio
0.60 0.58 0.42 0.43 0.52
Cash Conversion Cycle
393.23 1.02K 490.96 387.40 331.84
Days of Sales Outstanding
311.72 282.68 219.28 272.18 304.34
Days of Inventory Outstanding
129.73 927.83 332.98 137.54 56.47
Days of Payables Outstanding
48.22 192.19 61.29 22.32 28.97
Operating Cycle
441.45 1.21K 552.25 409.73 360.81
Cash Flow Ratios
Operating Cash Flow Per Share
0.29 0.16 0.15 0.21 0.21
Free Cash Flow Per Share
0.16 0.06 0.14 0.19 0.12
CapEx Per Share
0.13 0.10 0.01 0.01 0.09
Free Cash Flow to Operating Cash Flow
0.55 0.38 0.92 0.93 0.56
Dividend Paid and CapEx Coverage Ratio
1.11 0.80 1.37 14.10 2.29
Capital Expenditure Coverage Ratio
2.21 1.60 12.40 14.10 2.29
Operating Cash Flow Coverage Ratio
6.16 2.99 2.66 2.85 2.27
Operating Cash Flow to Sales Ratio
0.42 0.25 0.31 0.39 0.37
Free Cash Flow Yield
4.63%3.06%8.53%9.01%4.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.82 9.76 10.27 10.17 17.39
Price-to-Sales (P/S) Ratio
5.01 3.13 3.31 4.04 5.05
Price-to-Book (P/B) Ratio
1.93 1.14 1.03 1.37 2.04
Price-to-Free Cash Flow (P/FCF) Ratio
21.59 32.67 11.72 11.09 24.51
Price-to-Operating Cash Flow Ratio
11.84 12.26 10.77 10.31 13.82
Price-to-Earnings Growth (PEG) Ratio
0.30 0.39 -0.43 0.43 0.00
Price-to-Fair Value
1.93 1.14 1.03 1.37 2.04
Enterprise Value Multiple
7.82 4.93 4.20 4.91 8.55
Enterprise Value
19.37M 10.06M 7.75M 10.48M 15.11M
EV to EBITDA
7.82 4.93 4.20 4.91 8.55
EV to Sales
4.31 2.41 2.32 2.94 3.95
EV to Free Cash Flow
18.58 25.20 8.22 8.08 19.18
EV to Operating Cash Flow
10.19 9.46 7.56 7.51 10.82
Tangible Book Value Per Share
1.75 1.71 1.61 1.56 1.40
Shareholders’ Equity Per Share
1.75 1.72 1.61 1.57 1.42
Tax and Other Ratios
Effective Tax Rate
0.12 0.21 0.17 0.21 0.13
Revenue Per Share
0.67 0.63 0.50 0.54 0.57
Net Income Per Share
0.29 0.20 0.16 0.21 0.17
Tax Burden
0.88 0.79 0.83 0.79 0.87
Interest Burden
1.00 1.00 0.99 1.00 0.99
Research & Development to Revenue
0.44 0.48 0.00 0.46 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.00 0.80 0.95 0.99 1.26
Currency in EUR